Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DAP000662

Drug Information
SynonymsDisoprofol; MLS002454360; MLS001335999; propofol; 2,6-DIISOPROPYLPHENOL; SPBio_003031; C07523; NCGC00091538-04; Aquafol; Fresofol; BRN 1866484; DB00818; Propofol IDD-D; 2,6-Diisopropylphenol; Phenol, 2, 6-bis(1-methylethyl)-; NSC5105; Propofolum [Latin]; NCGC00091538-02; Rovi Brand of Propofol; Lopac-D126608; Propofol Fresenius; Diisopropylphenol; Ivofol; UNII-YI7VU623SF; NCGC00015389-02; D126608_ALDRICH; Prestwick0_000931; InChI=1/C12H18O/c1-8(2)10-6-5-7-11(9(3)4)12(10)13/h5-9,13H,1-4H; 4-06-00-03435 (Beilstein Handbook Reference); Diprivan Injectable emulsion; MolPort-001-794-517; S01-0189; Diprivan (TN); NCGC00091538-03; Zeneca Brand of Propofol; HMS2094E17; Ampofol; Abbott Brand of Propofol; 2,6-di(propan-2-yl)phenol; SPECTRUM1505022; C12H18O; CPD000059151; CPD-11437; HSDB 7123; NCGC00091538-01; CHEMBL526; BSPBio_000862; 2,6-Diisopropyl phenol; EU-0100437; AM-149; HMS2089O21; Propofol MCT; Fresenius Kabi Brand of Propofol; Prestwick3_000931; LS-996; 2,6-Bis(1-methylethyl)phenol; ICI 35,868; CID4943; Fresenius Brand of Propofol; Alpha Brand of Propofol; 2,6-Bis(Isopropyl)-phenol; MLS001066348; AC-2038; Propofol (JAN/USAN/INN); Recofol; SMR000059151; BPBio1_000950; NCGC00091538-06; D0617; Parnell Brand of Propofol; BPBio1_000969; 2,6 Diisopropylphenol; NCGC00015389-01; Phenol, 2,6-diisopropyl-; Disoprivan; D00549; Curamed Brand of Propofol; HMS1570L04; Diprivan; BIDD:GT0436; CCRIS 9000; NCGC00015389-09; 2, 6-Diisopropylphenol; Phenol, 2,6-bis(1-methylethyl)-; Juste Brand of Propofol; ICI35,868; PFL; AC1Q1OUI; Propofol [USAN:INN:BAN]; 28449-97-0; Dipravan; ST50405911; Jsp004266; BRD-K82255054-001-03-5; Biomol-NT_000248; ICI-35,868; ZINC00968303; Braun Brand of Propofol; ICI-35868; ICI 35868; NSC 5105; AI3-26295; Propofol Rovi; ICI35868; Rapinovet; EINECS 218-206-6; ZD-0859; ghl.PD_Mitscher_leg0.558; Propofol(2,6-Diisopropylphenol); Propofol-Lipuro; CHEBI:44915; CAS-2078-54-8; Propofolum; 2078-54-8; DDS-04F; D015742; nchembio.552-comp7; NCGC00091538-05; AB00513968; Propofol Abbott; Astra Brand of Propofol; SAM002264610; D126608; 2,6-bis(1-methylethyl)-phenol; AC1L1J9Y; Pisa Brand of Propofol; W505102_ALDRICH; 50356-15-5; Prestwick2_000931; AstraZeneca Brand of Propofol; Lopac0_000437; Schering Brand of Propofol; Prestwick1_000931; NCGC00015389-04    
Trade NameDiprivan    
IndicationAnestheticApproved    [1]

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Therapeutic ClassHypnotics and Sedatives    
CAS NumberCAS 2078-54-8
PubChem Compound IDCID 4943.    
PubChem Substance IDSID 9726.    
SuperDrug ATC IDN01AX10;    
SuperDrug CAS ID002078548;    
TargetFatty-acid amide hydrolaseInhibitor[2][3]
Ref 1Anaesthetic drugs: linking molecular actions to clinical effects. Curr Pharm Des. 2006;12(28):3665-79. To Reference
Ref 2Glutamate- and GABA-based CNS therapeutics. Curr Opin Pharmacol. 2006 Feb;6(1):7-17. To Reference
Ref 3The general anesthetic propofol increases brain N-arachidonylethanolamine (anandamide) content and inhibits fatty acid amide hydrolase. Br J Pharmacol. 2003 Jul;139(5):1005-13. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543